Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06400641
Status:
RECRUITING
Last Update Posted:
2024-05-06
First Post:
2024-02-20
Brief Title:
Study on the Feasibility of Continuous Glucose MonitoringCGM for Improving Blood Glucose Control in Severe Patients
Sponsor:
Chinese Medical Association
Organization:
Chinese Medical Association
Study Overview
Official Title:
CGM for Improving Blood Glucose Control in Severe Patients and the Feasibility of Automatic Drug Delivery in Combination With Insulin Pumps A Prospective Multi-center Randomized Controlled Study
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compared to traditional blood glucose monitoring TGM CGM can accurately capture asymptomatic hyperglycemia and hypoglycemia events that are missed by TGM accounting for 33 and 90 of cases respectively Real-time CGM provides instantaneous glucose levels and can also generate alarms for hypoglycemia and hyperglycemia based on preset glucose ranges assisting patients in making timely adjustments to their glucose levels Clinical studies have found that glucose control guided by real-time CGM is better and the decrease in glycosylated hemoglobin levels is positively correlated with the frequency of CGM use More importantly although glucose variability can be calculated using conventional blood glucose measurements taken every four to six hours to further assess precise changes in glucose levels more detailed and accurate continuous data are required In this respect CGM has unparalleled advantages over traditional blood glucose monitoringWhile the use of CGM in critically ill patients is still controversial
Detailed Description:
We conducted this clinical study to compare the effectiveness of CGM and traditional blood glucose monitoring in guiding blood glucose control in critically ill patients and to clarify the feasibility of using CGM for critically ill patients We also aimed to explore the possible factors that affect CGM in critically ill patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None